Trastuzumab Combined With Ramucirumab and Paclitaxel in Patients With Previously Treated Human Epidermal Growth Factor Receptor 2–Positive Advanced Gastric or Gastroesophageal Junction Cancer - Concepedia

Concepedia

Publication | Open Access

Trastuzumab Combined With Ramucirumab and Paclitaxel in Patients With Previously Treated Human Epidermal Growth Factor Receptor 2–Positive Advanced Gastric or Gastroesophageal Junction Cancer

DOI Full Paper Access

38

Citations

34

References

2023

Year

Chang Gon Kim, Minkyu Jung, Hyo Song Kim, Choong‐kun Lee, Hei‐Cheul Jeung, Dong‐Hoe Koo, Woo Kyun Bae, Dae Young Zang, Bum Jun Kim, Hyunki Kim,

Journal of Clinical Oncology

Abstract

Trastuzumab combined with ramucirumab and paclitaxel showed appreciable efficacy with manageable safety profiles in patients with previously treated HER2-positive G/GEJ cancer.

References

	Year	Citations

Page 1